Hypovolemic shock (dengue shock syndrome (DSS)) is the most common life-threatening complication of dengue. We conducted a genome-wide association study of 2,008 pediatric cases treated for DSS and 2,018 controls from Vietnam. Replication of the most significantly associated markers was carried out in an independent Vietnamese sample of 1,737 cases and 2,934 controls. SNPs at two loci showed genome-wide significant association with DSS. We identified a susceptibility locus at MICB (major histocompatibility complex (MHC) class I polypeptide-related sequence B), which was within the broad MHC region on chromosome 6 but outside the class I and class II HLA loci (rs3132468, P meta = 4.41 × 10 −11 , per-allele odds ratio (OR) = 1.34 (95% confidence interval: 1.23-1.46)). We identified associated variants within PLCE1 (phospholipase C, epsilon 1) on chromosome 10 (rs3765524, P meta = 3.08 × 10 −10 , per-allele OR = 0.80 (95% confidence interval: 0.75-0.86)). We identify two loci associated with susceptibility to DSS in people with dengue, suggesting possible mechanisms for this severe complication of dengue.
Dengue is an acute systemic viral infection caused by one of four serotypes of dengue virus, and globally it is the commonest mosquitoborne infection after malaria 1 . The burden of dengue is growing, with an estimated 100 million infections now occurring annually and with 2.5 billion people living in areas at risk of transmission. A wide variety of disease manifestations is seen, ranging from subclinical infection to severe and fatal disease. Severe dengue in children is characterized by an increase in vascular permeability that leads to life-threatening hypovolemic shock (DSS). This is often accompanied by thrombocytopenia and hemostatic dysfunction, which may result in severe bleeding. Children are at greatest risk of developing DSS, but with careful supportive care the case fatality rate is less than 1% (ref. 2). In southern Vietnam, serological studies have estimated that 85% of the population is exposed to dengue virus infection by the end of childhood (15 years old) 3 , whereas DSS is estimated to occur in less than 1% of exposed individuals 2 (see population controls in Online Methods). Epidemiological studies have suggested a genetic basis in the host for susceptibility to severe dengue, and various candidate gene studies of modest sample sizes have investigated this possibility [4] [5] [6] [7] [8] .
To estimate the genetic contribution underlying severe dengue, we genotyped 2,118 DNA samples from Vietnamese children with established or incipient DSS and 2,089 cord blood controls in a genome-wide association study (GWAS). After exclusion of samples for discrepancies between clinical and genetically inferred gender, for relatedness or for per-sample call rates of less than 95% ( Supplementary Fig. 1a ), there were 2,008 DSS cases and 2,018 controls available for analysis. The clinical and virological characteristics of the case population are described in Supplementary Table 1 . A total of 657,366 SNPs were initially included within the Illumina 660W Beadchip used for genome-wide genotyping. After various stringent quality-control exclusions ( Supplementary Fig. 1b ), a total of 481,342 SNPs were retained for downstream association analysis.
We conducted the routine GWAS statistical tests (Online Methods) and identified strong evidence of disease association at two distinct loci ( Fig. 1) : MICB on chromosome 6 and PLCE1 on chromosome 10, 1 1 4 0 VOLUME 43 | NUMBER 11 | NOVEMBER 2011 Nature GeNetics l e t t e r s which were both represented by SNPs that were close to the formal threshold for genome-wide significance (P = 5.38 × 10 −8 for rs3132468 at the MICB locus and P = 5.84 × 10 −8 for rs3740360 at the PLCE1 locus) ( Table 1 ). Together with the SNPs at MICB and PLCE1, a total of 85 SNPs exceeded P < 1 × 10 −4 on single SNP analysis (Supplementary Table 2 ). We were able to design assays for 72 out of these 85 SNPs using the Sequenom Mass-Array platform. The remaining 13 SNPs in the broad MHC region were refractory to assay design, thus necessitating the design of Applied Biosystems TaqMan assays for the sentinel SNP at MICB (rs3132468) and rs3134899 (also within MICB; GWAS P = 1.03 × 10 −4 , OR = 1.31). We then genotyped these 74 SNPs (72 non-MHC SNPs and two SNPs within MICB) in a replication sample of 1,824 DSS cases and 3,019 controls. We applied the same GWAS quality-control filters for the replication set: five SNPs had poor genotyping clusters and were excluded from analysis (Supplementary Table 2 ), and 132 samples (87 cases and 85 controls) had per-sample call rates of less than 95%; these were excluded from further analysis. This left 69 SNPs to be analyzed in 1,737 cases and 2,934 controls for the replication stage. In keeping with the GWAS observations, the strongest evidence of association was observed with SNPs at MICB (rs3132468, P repl = 9.32 × 10 −5 and rs3134899, P repl = 0.0082) and PLCE1 (three SNPs with P repl ranging from 5.23 × 10 −4 to 1.6 × 10 −4 , Table 1 ). Using inverse-variance weights, data from both the GWAS and replication cohorts (N = 3,745 DSS cases and N = 4,952 controls) were combined in a formal meta-analysis, and this identified strong evidence of association with rs3132468 at MICB (P = 4.41 × 10 −11 ; per-allele OR = 1.34 (95% confidence interval: 1.23-1.46)) and seven SNPs at PLCE1 (4.18 × 10 −9 ≤ P ≤ 3.08 × 10 −10 ; 0.75 ≤ OR ≤ 0.87, Table 1 ). To aid in refining the original signal of association, we performed imputation analysis at regions flanking both loci (30-32 Mb on chromosome 6 and 95.5-96.5 Mb on chromosome 10). This did not identify signals of association beyond those from the directly genotyped SNPs. The associations observed at MICB and PLCE1 were not specific to any dengue virus serotype on subgroup analysis of viral serotype, nor were they associated with the degree of thrombocytopenia or the degree of clinical shock (data not shown). Found within the broad MHC locus, MICB lies just outside both the type I and type II human leukocyte antigen (HLA) regions, ~140,000 base pairs centromeric to the nearest class I gene (HLA-B) and slightly less than 1 million base pairs away from the nearest class II gene (HLA-DRA). Apart from the peak signal at rs3132468 that was observed directly within MICB, 12 other SNPs in this region also showed association signals exceeding P < 1 × 10 −4 on single-SNP l e t t e r s analysis. We thus performed conditional analysis to assess the independence of the association observed at MICB rs3132468 from that of the nearby genes. Although the most significant SNP from the GWAS (rs3132468) could account for the majority of the association signal across the locus, we observed residual signals of association (0.0003 < P < 0.05) with SNPs near the vicinity of HLA-B and HLA-C as well as other neighboring genes (Supplementary Fig. 2a ). These residual associations indicate that definitive identification of MICB as a gene associated with DSS could be complicated by its location within the broad MHC region, which is known for its extensive linkage disequilibrium spanning multiple genes (Supplementary Fig. 2b) . This precludes definitive identification of the causative gene without extensive further fine-mapping and resequencing. With regard to PLCE1 on chromosome 10, association analysis conditioning for the lead SNP (rs3743060, directly genotyped) did not identify any secondary signals of association ( Supplementary Fig. 3a) , which suggests that the lead SNP-or any of its close correlates in complete linkage disequilibrium with it and confined within their distinct genomic region ( Supplementary Fig. 3b )-best explains the association signal at the locus. We did not observe any evidence of epistasis between SNPs at MICB and PLCE1 (P = 0.11). MICB seems to be a promising candidate on the basis of the present strength of the statistical associations observed in the chromosome 6 hit region. MICB encodes an inducible activating ligand for the NKG2D type II receptor on natural killer and CD8 + T cells 9, 10 . Ligation of NKG2D by MICB stimulates antiviral effector functions in natural killer cells, including cytokine expression and the cytolytic response 11 . We have previously reported that MICB, together with other genes associated with natural killer cell activation, are highly expressed in the leukocytes of people with acute dengue 12 . We therefore propose that the association between the MICB rs3132468 genotype and susceptibility to severe dengue might reflect altered or dysfunctional natural killer and/or CD8 + T cell activation early in infection that results in a higher viral burden in vivo, which is a recognized factor in clinical outcome 13, 14 . The recent finding that a SNP near the closely related MICA gene (rs2596542) is associated with hepatitis C virus-induced hepatocellular carcinoma is suggestive of a pivotal role for MIC proteins in the pathogenesis of these Flaviviridae infections 15 .
Mutations within PLCE1 are associated with nephrotic syndrome 16 . Nephrotic syndrome is a kidney disorder in which dysfunction of the glomerular basement membrane results in proteinuria and hypoproteinemia that, when severe, leads to reduced vascular oncotic pressure and edema. These elements of nephrotic syndrome have striking similarities with severe dengue and suggest a key role for PLCE1 in maintaining normal vascular endothelial cell barrier function. In summary, our study identifies common variants in MICB and PLCE1 that are associated with susceptibility to severe dengue. 
ONLINe MetHODS
Patient enrollment and diagnosis. Blood samples for genotyping were collected from patients enrolled into one of two research studies of children with dengue. In both studies, children were eligible if they were ≤15 years of age and had clinical signs, symptoms and hematological findings that led to a clinical diagnosis of incipient or established DSS, as defined by World Health Organization criteria (see URLs). All patients were resuscitated with bolus intravenous fluid therapy (≥15 ml per kg body weight in the first hour). Summary laboratory and clinical findings were recorded into case record forms during the inpatient period until the patient was discharged from hospital, died or was transferred to another hospital. Blood samples for research and diagnostic tests were collected at the time of enrollment and again before patient discharge from hospital. The first study enrolled patients in the pediatric intensive care unit of the Hospital for Tropical Diseases ( Cord blood DNA samples. Blood from the cord of newborn infants was collected in one of two prospective studies. The first study was conducted at Hung Vuong Hospital (Ho Chi Minh City, Vietnam) between 2004 and 2006. The second study was conducted at Hung Vuong Hospital and Dong Thap Hospital between 2009 and 2010. All participants gave written informed consent to participate. The Scientific and Ethical Committees of each study site approved the study protocols, as did the Oxford University Tropical Research Ethical Committee. DNA was extracted from cord blood using Nucleon BACC Genomic DNA Extraction Kits (GE Healthcare, USA).
The use of population controls. The number of potentially misclassified cord blood controls in the GWAS and replication stages was estimated to be 11 (out of 2,018) in the GWAS stage and 15 (out of 2,934) in the replication stage, based on the following three assumptions: that all individuals in a given birth cohort will experience two sequential infections by different serotypes during their lifetime 17 ; that only up to 25% of these infections are clinically apparent [18] [19] [20] [21] [22] [23] ; and that 2% of clinically apparent secondary infections develop DSS. These assumptions estimate a lifetime population risk of DSS to be 0.5%. This is consistent with estimates of the prevalence of DSS cases expected over the first 15 years in a given birth cohort under the assumption that the incidence of DSS is constant (DSS incidence in southern Vietnam in 2009 was 26.59/100,000; based on statistics obtained from the Dengue Control program, Ministry of Health Vietnam, 2010). Under this assumption, we would expect 0.4% of a birth cohort to experience DSS before the age of 15 years.
Genotyping. Cases and controls were randomized on plates and were genotyped with Illumina Human 660W Quad BeadChips following manufacturer instructions. The successful use of this chip has been previously documented 24 . For the replication stage, 72 of the selected SNPs that were not on the broad MHC region were genotyped with the Sequenom (see URLs) MassArray primer extension iPLEX system. MICB rs3132468 and rs3134899 were genotyped using the Applied Biosystems (see URLs) TaqMan platform.
Statistical analysis. Stringent quality control filters were applied to remove poorly performing SNPs and samples using tools implemented in PLINK (version 1.7) 25 . The quality control criteria were as follows: SNPs that had genotypes with more than 5% missing, showed gross departure from Hardy-Weinberg equilibrium (a departure of P < 10 −7 ) or had a minor allele frequency below 1% were excluded from downstream analysis. For sample quality control, samples with an overall genotyping call rate of <95% were excluded from analysis. The remaining samples were then subjected to biological relationship verification by using the principle of variability in allele sharing according to the degree of relationship. Identity-by-state information was derived using PLINK 25 . For those pairs of individuals who showed evidence of cryptic relatedness (possibly owing to duplicated or biologically related samples), we removed the sample with the lower call rate before performing principal component analysis. Principal component analysis was undertaken to account for spurious associations resulting from ancestral differences of individual SNPs 26 , and principal component plots were performed using the R statistical program package (R Project, see URLs).
For both the GWAS and replication stages, analysis of association with DSS was carried out using a 1 degree of freedom score-based test. This test models for a trend per copy of the minor allele on disease risk and has been extensively described 27, 28 . It has the best statistical power to detect association for complex traits across a wide range of alternative hypotheses, with the exception of those involving rare recessive variants 29 . The threshold for significant independent replication was set at P < 0.05 in the combined replication data sets 30 .
Meta-analysis was conducted using inverse variance weights for each cohort, which calculates an overall Z statistic, corresponding P value and accompanying ORs for each SNP analyzed 30, 31 . Genotyping clusters were directly visualized for the 85 SNPs exceeding P < 1 × 10 −4 and confirmed to be of good quality before inclusion for statistical analysis. Supplementary Figure 4 shows the cluster plots for MICB rs3132468 and PLCE1 rs3740360, the two SNPs that showed P < 10 −7 in the GWAS stage.
Analysis of linkage disequilibrium was performed using Haploview 32 .
Statistical findings after routine GWAS analysis. Analysis of genetic ancestry using principal components revealed no significant population substructure between the DSS cases and controls (Supplementary Fig. 5a ). As the individual principal components were nonsignificant (Bonferroni corrected P > 0.05, Supplementary Table 3 ) when tested as continuous covariates using logistic regression, we did not adjust for them in subsequent association analysis. Single SNP analysis was performed using logistic regression assuming additive genetic effects relating genotype dosage (scoring for 0, 1 or 2 copies of the minor allele) to DSS. A quantile-quantile plot of the single SNP analysis showed a clear excess of extreme P values compared to the null distribution ( Supplementary Fig. 5b ). As this excess was observed against a background of minimal genome-wide inflation of test statistics (λgc = 1.024), it excludes the possibility of substantial population substructure and differential genotyping call rate between cases and controls as a reason for the excess. Instead, this suggests that at least some of these extreme P values (P < 1 × 10 −4 ) may represent true genetic associations with DSS.
